MyoPax

myopax.com
startup-icon Start-up

MyoPax GmbH

Koppenplatz 5
10115 Berlin
Germany
myopax.com
Profile Products News

About MyoPax

We develop advanced regenerative stem cell therapies to fight the devastating consequences of muscle diseases.

Read more about MyoPax

Advertisement

Advanced TFF Technology for Enhanced Monoclonal Antibody Concentration and Processing
Advanced TFF Technology for Enhanced Monoclonal Antibody Concentration and Processing
High-Performance Sterilizing-Grade Filtration for Solvents and Oily Formulations
High-Performance Sterilizing-Grade Filtration for Solvents and Oily Formulations
Gentle Counterflow Centrifugation for Superior Cell Processing Results
Gentle Counterflow Centrifugation for Superior Cell Processing Results

Product portfolio of MyoPax

Product portfolio

Show all

Advertisement

Chemically Defined Cell Culture Media for Viral Vector and Gene Therapy Applications
Chemically Defined Cell Culture Media for Viral Vector and Gene Therapy Applications
High-Recovery Anion Exchange Membrane Chromatography for Lentiviral Vector Purification
High-Recovery Anion Exchange Membrane Chromatography for Lentiviral Vector Purification
Microplate reading, made easy: flexible multi-mode microplate reader with simplified assay setup
Microplate reading, made easy: flexible multi-mode microplate reader with simplified assay setup

News about MyoPax

MyoPax

27-May-2026 | business & finance

Berlin honors outstanding deep-tech companies

Deep Tech Award 2026 presented for the first time at the Deep Tech Momentum conference

Read news
MyoPax

02-Dec-2024 | business & finance

Bayer further expands global incubator network with Bayer Co.Lab Berlin and welcomes MyoPax as first resident

Investment underscores Bayer´s commitment to creating a leading life science ecosystem for innovative therapies in Berlin

Read news
MyoPax

01-Aug-2023 | research and development

New muscle therapy gets fast-track boost

Berlin start-up could soon be helping children with previously incurable muscle diseases thanks to an accelerated approval process

Read news
MyoPax

22-Sep-2022 | business & finance

Regenerative therapies for previously incurable muscle diseases

Million euro support for MyoPax

Read news
Show more news about MyoPax

Advertisement

Maximum binding capacity in ion exchange chromatography
Maximum binding capacity in ion exchange chromatography
Digital membrane chromatography opens up new horizons in protein analysis
Digital membrane chromatography opens up new horizons in protein analysis
Advanced Virus Quantification for Real-Time Process Control
Advanced Virus Quantification for Real-Time Process Control

Here you will find MyoPax GmbH

Last viewed contents

Phosphoenolpyruvate_carboxykinase

Go to page